Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 43.97B | 40.95B | 37.32B | 30.79B | 36.56B |
Gross Profit | 13.42B | 13.59B | 12.19B | 9.20B | 11.76B |
EBITDA | 4.61B | 4.47B | 3.21B | 1.16B | 3.46B |
Net Income | 3.50B | 2.80B | 601.00M | 1.14B | -217.00M |
Balance Sheet | |||||
Total Assets | 45.20B | 41.47B | 41.78B | 36.92B | 36.48B |
Cash, Cash Equivalents and Short-Term Investments | 10.29B | 9.37B | 8.13B | 6.99B | 7.81B |
Total Debt | 2.74B | 1.40B | 3.11B | 2.86B | 2.31B |
Total Liabilities | 14.44B | 13.11B | 16.88B | 13.35B | 13.45B |
Stockholders Equity | 30.76B | 28.37B | 24.89B | 23.57B | 22.83B |
Cash Flow | |||||
Free Cash Flow | 2.68B | 2.61B | 1.12B | -1.57B | 722.00M |
Operating Cash Flow | 3.27B | 3.74B | 1.73B | -1.07B | 1.90B |
Investing Cash Flow | -2.81B | -569.00M | -666.00M | 214.00M | -1.09B |
Financing Cash Flow | 477.00M | -1.97B | 74.00M | 42.00M | -679.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥4.56B | 3.42 | ― | 1.33% | 13.09% | ||
74 Outperform | ¥34.12B | 5.33 | 4.69% | -6.41% | 25.30% | ||
74 Outperform | ¥41.62B | 18.30 | 2.78% | -1.19% | -30.24% | ||
73 Outperform | ¥29.49B | 7.71 | 2.66% | 16.42% | 79.16% | ||
61 Neutral | $36.28B | 7.09 | -7.27% | 1.97% | 7.76% | -8.56% | |
49 Neutral | ¥3.79B | 29.94 | 2.02% | 0.35% | ― |